stage iv uterine corpus cancer

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer Trial in Philadelphia (Management of Therapy Complications,

Terminated
  • Lymphedema
  • +18 more
  • Management of Therapy Complications
  • Quality-of-Life Assessment
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jun 11, 2021

Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

Completed
  • Malignant Female Reproductive System Neoplasm
  • +38 more
  • Cognitive Behavior Therapy
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 7, 2021

Prognostic Biomarkers in Patients With Endometrial Cancer

Completed
  • Endometrial Adenocarcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Aug 22, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous

Completed
  • Endometrial Adenocarcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Mar 17, 2016

Tumor Tissue Samples From Stage III, Stage IV, or Recurrent

Not yet recruiting
  • Recurrent Uterine Corpus Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jun 3, 2015

Response in Tissue Samples From Patients With Endometrial Cancer

Not yet recruiting
  • Stage I Uterine Corpus Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Study of Socioeconomic and Demographic Variables
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 27, 2015

Biomarkers in Samples From Patients With Endometrial Cancer

Not yet recruiting
  • Lynch Syndrome
  • +5 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 27, 2015

Blood and Tissue Samples From Patients With Uterine Cancer

Not yet recruiting
  • Endometrial Serous Adenocarcinoma
  • +4 more
  • Diagnostic Laboratory Biomarker Analysis
  • +5 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 27, 2015

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia

Completed
  • Endometrial Adenocarcinoma
  • +4 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Dec 29, 2014

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer Trial in Philadelphia

Completed
  • Endometrial Clear Cell Adenocarcinoma
  • +3 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Dec 29, 2014